Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current ratio changed +23.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed +13047.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 4 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +66.6% from the comparable as-filed period.
Operating margin changed +1456 basis points from the comparable as-filed period.
Operating cash flow changed +67.6% from the comparable as-filed period.
Gross margin changed +554 basis points from the comparable as-filed period.
Operating income changed +494.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed +885 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capital expenditure changed +400.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -804 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -16.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -14.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed -347.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +26.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -29.2% from the comparable as-filed period.
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.